In this section you can read all the latest news about counterfeit and substandard medicines from around Europe and the world.
Article in the highly subscribed EurActiv journal
Commission urged to consider common regulatory framework for nanomedicines” supports the EAASM goals for nanomedicines and nanosimilars for regulatory clarity The lack of a fit-for-purpose
PRESS RELEASE: New report ‘Patient Safety and Nanomedicines: the need for a centralised regulatory procedure’ calls to ensure patient safety through regulatory clarity
Brussels, 17 September 2020 – On World Patient Safety Day 2020, the European Alliance for Access to Safe Medicines along with several organisations launches its
EVENT: Patient safety and the implementation of the Falsified Medicines Directive in the hospital environment – 30 September – Free online meeting
Led by MEP Manuel Pizarro (S&D) this live webinar will be especially useful for hospital pharmacists and their teams across the EU. Following the entry
New scientific paper : Patient safety issues associated with the use of compounded medicines as alternatives to approved pharmaceutical products in Europe and how best practice can improve outcomes
BACKGROUND: Pharmaceutical compounding allows individuals with special requirements access to medicines. Compounding can also be used to provide cheaper alternatives to commercially produced medicines which